Protective Effect of Resveratrol against Glioblastoma: A Review

Milad Ashrafizadeh1, Reza Mohammadinejad2, Tahereh Farkhondeh3

  • 1Faculty of Engineering and Natural Sciences, Sabanci University, Orta Mahalle, Üniversite Caddesi No. 27, Orhanlı, Tuzla, 34956 Istanbul, Turkey.

Abstract

Insights

Resveratrol (Res) shows promise in treating Glioblastoma (GBM), a common brain tumor. This natural compound inhibits GBM cell growth and migration by affecting key molecular pathways.

Area of Science:

  • Neuro-oncology
  • Natural product chemistry
  • Molecular pharmacology

Background:

  • Glioblastoma (GBM) is a prevalent and aggressive central nervous system tumor.
  • Current treatments for GBM remain insufficient, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the potential therapeutic effects of Resveratrol (Res) against Glioblastoma (GBM).
  • To elucidate the underlying molecular mechanisms of Resveratrol's action in GBM therapy.

Main Methods:

  • A comprehensive literature search was conducted across major scientific databases (PubMed, Scopus, Web of Science, Google Scholar).
  • Keywords included Resveratrol, Glioblastoma, Brain tumor, Cancer therapy, and Medicinal herbs, with data collected up to July 2020.

Main Results:

  • Resveratrol, a plant-derived polyphenol, exhibits antioxidant, anti-inflammatory, and anti-tumor properties.
  • Its ability to cross the blood-brain barrier makes it a suitable candidate for brain tumor treatment.
  • Resveratrol modulates various molecular signaling pathways crucial in cancer progression.

Conclusions:

  • Resveratrol administration demonstrates therapeutic benefits in Glioblastoma (GBM) treatment.
  • It effectively inhibits GBM cell proliferation, viability, and migration through molecular pathway modulation.